annual CFO:
$7.78B-$107.74M(-1.37%)Summary
- As of today (August 20, 2025), GSK annual cash flow from operations is $7.78 billion, with the most recent change of -$107.74 million (-1.37%) on December 31, 2024.
- During the last 3 years, GSK annual CFO has fallen by -$2.12 billion (-21.43%).
- GSK annual CFO is now -37.88% below its all-time high of $12.53 billion, reached on December 31, 2008.
Performance
GSK Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$2.47B+$1.04B(+73.46%)Summary
- As of today (August 20, 2025), GSK quarterly cash flow from operations is $2.47 billion, with the most recent change of +$1.04 billion (+73.46%) on June 30, 2025.
- Over the past year, GSK quarterly CFO has increased by +$1.36 billion (+122.04%).
- GSK quarterly CFO is now -51.81% below its all-time high of $5.12 billion, reached on December 31, 2018.
Performance
GSK quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$9.45B+$1.36B(+16.75%)Summary
- As of today (August 20, 2025), GSK TTM cash flow from operations is $9.45 billion, with the most recent change of +$1.36 billion (+16.75%) on June 30, 2025.
- Over the past year, GSK TTM CFO has increased by +$746.20 million (+8.58%).
- GSK TTM CFO is now -27.90% below its all-time high of $13.10 billion, reached on June 30, 2022.
Performance
GSK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GSK Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.4% | +122.0% | +8.6% |
| 3 y3 years | -21.4% | +55.6% | -27.9% |
| 5 y5 years | -15.4% | -17.4% | -15.1% |
GSK Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.4% | at low | -31.8% | +2036.5% | -27.9% | +102.9% |
| 5 y | 5-year | -21.4% | at low | -47.6% | +2036.5% | -27.9% | +102.9% |
| alltime | all time | -37.9% | +344.2% | -51.8% | +190.3% | -27.9% | +440.0% |
GSK Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.47B(+73.5%) | $9.45B(+16.8%) |
| Mar 2025 | - | $1.42B(-49.8%) | $8.09B(+2.9%) |
| Dec 2024 | $7.78B(-1.4%) | $2.83B(+4.1%) | $7.86B(-9.1%) |
| Sep 2024 | - | $2.72B(+145.2%) | $8.64B(-0.6%) |
| Jun 2024 | - | $1.11B(-6.7%) | $8.70B(-2.6%) |
| Mar 2024 | - | $1.19B(-67.1%) | $8.93B(+13.7%) |
| Dec 2023 | $7.89B(-3.3%) | $3.62B(+30.2%) | $7.85B(+31.2%) |
| Sep 2023 | - | $2.78B(+107.6%) | $5.98B(+28.6%) |
| Jun 2023 | - | $1.34B(+1060.3%) | $4.65B(-5.0%) |
| Mar 2023 | - | $115.43M(-93.4%) | $4.90B(-39.5%) |
| Dec 2022 | $8.16B(-17.6%) | $1.75B(+20.6%) | $8.09B(-26.7%) |
| Sep 2022 | - | $1.45B(-8.5%) | $11.05B(-15.7%) |
| Jun 2022 | - | $1.58B(-52.1%) | $13.10B(+1.8%) |
| Mar 2022 | - | $3.31B(-29.6%) | $12.87B(+30.1%) |
| Dec 2021 | $9.91B(+1.0%) | $4.70B(+34.2%) | $9.89B(+0.8%) |
| Sep 2021 | - | $3.50B(+159.6%) | $9.82B(+33.6%) |
| Jun 2021 | - | $1.35B(+301.2%) | $7.35B(-18.2%) |
| Mar 2021 | - | $336.45M(-92.7%) | $8.98B(-8.3%) |
| Dec 2020 | $9.81B(+6.6%) | $4.63B(+347.5%) | $9.80B(+8.3%) |
| Sep 2020 | - | $1.03B(-65.4%) | $9.04B(-18.7%) |
| Jun 2020 | - | $2.99B(+159.5%) | $11.12B(+16.7%) |
| Mar 2020 | - | $1.15B(-70.3%) | $9.53B(+4.5%) |
| Dec 2019 | $9.20B(-11.1%) | $3.87B(+24.5%) | $9.12B(-12.0%) |
| Sep 2019 | - | $3.11B(+122.7%) | $10.36B(+4.9%) |
| Jun 2019 | - | $1.40B(+88.4%) | $9.88B(-1.4%) |
| Mar 2019 | - | $741.04M(-85.5%) | $10.02B(-3.9%) |
| Dec 2018 | $10.36B(+29.5%) | $5.12B(+95.1%) | $10.42B(+21.7%) |
| Sep 2018 | - | $2.62B(+70.4%) | $8.57B(+2.2%) |
| Jun 2018 | - | $1.54B(+34.6%) | $8.38B(+7.7%) |
| Mar 2018 | - | $1.14B(-64.9%) | $7.78B(-2.4%) |
| Dec 2017 | $7.99B(+1.1%) | $3.26B(+33.8%) | $7.97B(-2.7%) |
| Sep 2017 | - | $2.44B(+159.3%) | $8.19B(+1.0%) |
| Jun 2017 | - | $940.07M(-29.4%) | $8.11B(-5.9%) |
| Mar 2017 | - | $1.33B(-61.8%) | $8.62B(+9.1%) |
| Dec 2016 | $7.91B(+170.8%) | $3.48B(+47.7%) | $7.91B(+26.0%) |
| Sep 2016 | - | $2.36B(+62.9%) | $6.28B(+37.6%) |
| Jun 2016 | - | $1.45B(+135.0%) | $4.56B(+49.0%) |
| Mar 2016 | - | $616.16M(-66.7%) | $3.06B(+4.4%) |
| Dec 2015 | $2.92B(-60.9%) | $1.85B(+187.6%) | $2.93B(-30.8%) |
| Sep 2015 | - | $644.02M(-1327.2%) | $4.24B(-24.4%) |
| Jun 2015 | - | -$52.48M(-110.8%) | $5.60B(-14.8%) |
| Mar 2015 | - | $487.92M(-84.6%) | $6.58B(-12.4%) |
| Dec 2014 | $7.47B(-27.2%) | $3.16B(+57.1%) | $7.51B(-0.1%) |
| Sep 2014 | - | $2.01B(+118.5%) | $7.52B(-12.0%) |
| Jun 2014 | - | $919.98M(-35.2%) | $8.55B(-12.8%) |
| Mar 2014 | - | $1.42B(-55.2%) | $9.80B(-4.5%) |
| Dec 2013 | $10.26B(+76.3%) | $3.17B(+4.2%) | $10.26B(+6.9%) |
| Sep 2013 | - | $3.04B(+39.7%) | $9.60B(+59.4%) |
| Jun 2013 | - | $2.18B(+15.9%) | $6.02B(-3.0%) |
| Mar 2013 | - | $1.88B(-25.1%) | $6.21B(+6.6%) |
| Dec 2012 | $5.82B(-35.2%) | $2.50B(-565.0%) | $5.82B(-6.2%) |
| Sep 2012 | - | -$538.59M(-122.8%) | $6.21B(-35.8%) |
| Jun 2012 | - | $2.36B(+58.4%) | $9.68B(+7.8%) |
| Mar 2012 | - | $1.49B(-48.4%) | $8.98B(-0.5%) |
| Dec 2011 | $8.98B | $2.89B(-1.4%) | $9.02B(+13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $2.93B(+75.7%) | $7.95B(+18.4%) |
| Jun 2011 | - | $1.67B(+8.7%) | $6.72B(-13.5%) |
| Mar 2011 | - | $1.53B(-15.8%) | $7.77B(-18.1%) |
| Dec 2010 | $9.49B(-15.7%) | $1.82B(+7.5%) | $9.49B(-11.2%) |
| Sep 2010 | - | $1.69B(-37.7%) | $10.69B(-14.0%) |
| Jun 2010 | - | $2.72B(-16.4%) | $12.43B(+3.3%) |
| Mar 2010 | - | $3.25B(+7.8%) | $12.03B(+7.0%) |
| Dec 2009 | $11.25B(-10.2%) | $3.02B(-12.2%) | $11.25B(+2.3%) |
| Sep 2009 | - | $3.44B(+48.0%) | $11.00B(-2.0%) |
| Jun 2009 | - | $2.32B(-6.0%) | $11.22B(-0.9%) |
| Mar 2009 | - | $2.47B(-10.7%) | $11.33B(-9.6%) |
| Dec 2008 | $12.53B(+3.6%) | $2.77B(-24.4%) | $12.53B(-0.0%) |
| Sep 2008 | - | $3.66B(+50.7%) | $12.53B(+0.1%) |
| Jun 2008 | - | $2.43B(-33.9%) | $12.52B(-1.4%) |
| Mar 2008 | - | $3.67B(+32.8%) | $12.71B(+4.7%) |
| Dec 2007 | $12.09B(+54.3%) | $2.77B(-24.3%) | $12.14B(+1.0%) |
| Sep 2007 | - | $3.65B(+39.8%) | $12.02B(+43.6%) |
| Jun 2007 | - | $2.61B(-15.9%) | $8.37B(+7.4%) |
| Mar 2007 | - | $3.11B(+17.2%) | $7.79B(+0.1%) |
| Dec 2006 | $7.84B(-26.6%) | $2.65B(>+9900.0%) | $7.78B(+4.9%) |
| Sep 2006 | - | $50.10K(-100.0%) | $7.42B(-30.5%) |
| Jun 2006 | - | $2.04B(-34.2%) | $10.67B(-6.6%) |
| Mar 2006 | - | $3.09B(+35.4%) | $11.43B(+6.7%) |
| Dec 2005 | $10.68B(+22.0%) | $2.29B(-29.8%) | $10.71B(+6.8%) |
| Sep 2005 | - | $3.26B(+16.7%) | $10.03B(+4.4%) |
| Jun 2005 | - | $2.79B(+17.2%) | $9.61B(+5.0%) |
| Mar 2005 | - | $2.38B(+48.6%) | $9.15B(+5.7%) |
| Dec 2004 | $8.75B(+8.1%) | $1.60B(-43.5%) | $8.66B(-0.9%) |
| Sep 2004 | - | $2.84B(+21.6%) | $8.74B(-1.7%) |
| Jun 2004 | - | $2.33B(+23.6%) | $8.88B(+8.6%) |
| Mar 2004 | - | $1.89B(+12.4%) | $8.18B(+2.1%) |
| Dec 2003 | $8.10B(-1.7%) | $1.68B(-43.7%) | $8.02B(-1.7%) |
| Sep 2003 | - | $2.98B(+82.8%) | $8.15B(+6.5%) |
| Jun 2003 | - | $1.63B(-5.2%) | $7.66B(-8.5%) |
| Mar 2003 | - | $1.72B(-5.2%) | $8.37B(+1.3%) |
| Dec 2002 | $8.24B(+21.1%) | $1.81B(-27.1%) | $8.26B(-4.0%) |
| Sep 2002 | - | $2.49B(+6.3%) | $8.61B(+8.7%) |
| Jun 2002 | - | $2.34B(+44.9%) | $7.92B(+4.9%) |
| Mar 2002 | - | $1.62B(-25.2%) | $7.55B(+11.2%) |
| Dec 2001 | $6.81B(+11.6%) | $2.16B(+20.2%) | $6.79B(+257.4%) |
| Sep 2001 | - | $1.80B(-9.0%) | $1.90B(-46.1%) |
| Jun 2001 | - | $1.97B(+130.3%) | $3.52B(+101.4%) |
| Mar 2001 | - | $857.53M(-131.4%) | $1.75B(-37.7%) |
| Dec 2000 | $6.10B(+5.6%) | -$2.73B(-179.8%) | $2.81B(-49.3%) |
| Sep 2000 | - | $3.42B(+1599.9%) | $5.54B(+161.6%) |
| Jun 2000 | - | $201.19M(-89.5%) | $2.12B(+10.5%) |
| Mar 2000 | - | $1.92B | $1.92B |
| Dec 1999 | $5.78B(+108.2%) | - | - |
| Dec 1998 | $2.77B(-7.5%) | - | - |
| Dec 1997 | $3.00B(+1.7%) | - | - |
| Dec 1996 | $2.95B(-32.8%) | - | - |
| Dec 1995 | $4.38B(+79.4%) | - | - |
| Jun 1994 | $2.44B(+3.4%) | - | - |
| Jun 1993 | $2.36B(+20.7%) | - | - |
| Jun 1992 | $1.96B(+11.7%) | - | - |
| Jun 1991 | $1.75B | - | - |
FAQ
- What is GSK plc annual cash flow from operations?
- What is the all time high annual CFO for GSK plc?
- What is GSK plc annual CFO year-on-year change?
- What is GSK plc quarterly cash flow from operations?
- What is the all time high quarterly CFO for GSK plc?
- What is GSK plc quarterly CFO year-on-year change?
- What is GSK plc TTM cash flow from operations?
- What is the all time high TTM CFO for GSK plc?
- What is GSK plc TTM CFO year-on-year change?
What is GSK plc annual cash flow from operations?
The current annual CFO of GSK is $7.78B
What is the all time high annual CFO for GSK plc?
GSK plc all-time high annual cash flow from operations is $12.53B
What is GSK plc annual CFO year-on-year change?
Over the past year, GSK annual cash flow from operations has changed by -$107.74M (-1.37%)
What is GSK plc quarterly cash flow from operations?
The current quarterly CFO of GSK is $2.47B
What is the all time high quarterly CFO for GSK plc?
GSK plc all-time high quarterly cash flow from operations is $5.12B
What is GSK plc quarterly CFO year-on-year change?
Over the past year, GSK quarterly cash flow from operations has changed by +$1.36B (+122.04%)
What is GSK plc TTM cash flow from operations?
The current TTM CFO of GSK is $9.45B
What is the all time high TTM CFO for GSK plc?
GSK plc all-time high TTM cash flow from operations is $13.10B
What is GSK plc TTM CFO year-on-year change?
Over the past year, GSK TTM cash flow from operations has changed by +$746.20M (+8.58%)